TMCnet News
Research and Markets: Singapore and Malaysia In-Vitro Diagnostics (IVD) Market Report 2014DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/vl56hm/vd_in_singapore) has announced the addition of the "VD in Singapore and Malaysia" report to their offering. IVD manufacturers seeking marginal growth are focusing on regional markets. The whole of Southeast Asia represents a unique opportunity for healthcare providers and their various industry suppliers, including the in vitro diagnostics (IVD) industry. In this report two nations are detailed that are expected to provide opportunity for IVD manufacturers: Singapore and Malaysia. The nexus of regional trade, and a leading port and center for the entire Asia-Pacific, is Singapore. The city-state features the most developed and highest rated healthcare system in Southeast Asia and serves as the headquarters and regional manufacturing center for some medical device, biotechnology, IVD, and pharmaceutical companies. Its neighbor Malaysia, an upper middle-income nation has arguably the second-most developed healthcare system in Southeast Asia. Through Singapore or Kuala Lumur, IVD companies have access to approximately 35 million potential patients, over 700,000 annual medical tourists, and healthcare systems with higher per capita spending than anywhere else in Southeast Asia or anywhere in Asia outside of Japan, Australia, or Korea. Singapore and Malaysia present IVD markets and opportunities with healthy prospects and solid fundaments in clinical demand. This IVD in Singapore and Malaysia report contains the following data:
Key Topics Covered: Chapter One: Introduction
Chapter Two: IVD Market Analysis
Chapter Three: IVD Companies And Market Leaders
For more information visit http://www.researchandmarkets.com/research/vl56hm/vd_in_singapore
|
